Northern Trust
MBIO icon

Northern Trust’s Mustang Bio MBIO Stock Holding History

Northern Trust’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-338
Closed -$2.99K – 4478
2024
Q4 		$2.99K Hold
338
– – ﹤0.01% 4440
2024
Q3 		$3.98K Hold
338
– – ﹤0.01% 4405
2024
Q2 		$8K Sell
338
-3
-0.9% -$57 ﹤0.01% 4390
2024
Q1 		$17.7K Hold
341
– – ﹤0.01% 4348
2023
Q4 		$23K Buy
+341
New +$27.1K ﹤0.01% 4349
2023
Q2 		– Sell
-190
Closed -$52.3K – 4571
2023
Q1 		$52.3K Buy
190
+19
+11% +$7.79K ﹤0.01% 4254
2022
Q4 		$50.6K Hold
171
– – ﹤0.01% 4284
2022
Q3 		$60K Sell
171
-1
-0.6% -$463 ﹤0.01% 4280
2022
Q2 		$76K Sell
172
-656
-79% -$363K ﹤0.01% 4275
2022
Q1 		$627K Buy
828
+4
+0.5% +$3.29K ﹤0.01% 3644
2021
Q4 		$1.03M Sell
824
-77
-9% -$124K ﹤0.01% 3534
2021
Q3 		$1.82M Buy
901
+30
+3% +$64.4K ﹤0.01% 3339
2021
Q2 		$2.17M Buy
871
+175
+25% +$429K ﹤0.01% 3314
2021
Q1 		$1.73M Sell
696
-39
-5% -$116K ﹤0.01% 3317
2020
Q4 		$2.09M Buy
735
+274
+59% +$655K ﹤0.01% 3171
2020
Q3 		$1.09M Sell
461
-1
-0.2% -$2.46K ﹤0.01% 3362
2020
Q2 		$1.1M Buy
462
+34
+8% +$79.5K ﹤0.01% 3320
2020
Q1 		$860K Buy
428
+17
+4% +$43.6K ﹤0.01% 3279
2019
Q4 		$1.26M Buy
411
+6
+1% +$13.7K ﹤0.01% 3315
2019
Q3 		$989K Buy
405
+101
+33% +$276K ﹤0.01% 3398
2019
Q2 		$840K Buy
304
+64
+27% +$183K ﹤0.01% 3413
2019
Q1 		$614K Hold
240
– – ﹤0.01% 3491
2018
Q4 		$529K Sell
240
-1
-0.4% -$3.04K ﹤0.01% 3537
2018
Q3 		$1.07M Buy
241
+3
+1% +$15K ﹤0.01% 3454
2018
Q2 		$1.23M Buy
238
+200
+526% +$1.26M ﹤0.01% 3405
2018
Q1 		$310K Buy
38
+17
+81% +$145K ﹤0.01% 3694
2017
Q4 		$192K Buy
+21
New +$162K ﹤0.01% 3827

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust's MBIO Position: Q1 2025 in Review

Northern Trust sold out of Mustang Bio (MBIO) in Q1 2025, closing a stake of 338 shares — an estimated $2.99K sold.

Northern Trust first reported a position in MBIO in Q4 2017 and held it in 27 quarters. The position peaked at $2.17M in Q2 2021. 16 funds tracked by Wall St. Rank hold MBIO as of Q1 2025.

  • Northern Trust reported no remaining Mustang Bio position as of Q1 2025 after selling out during the quarter.
  • Northern Trust sold 338 Mustang Bio shares in Q1 2025, an estimated $2.99K.
  • Northern Trust first reported a position in Mustang Bio in Q4 2017 and held it in 27 quarters.
  • Northern Trust's Mustang Bio position peaked at $2.17M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2025.

Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.